Hypoglycemia-associated autonomic failure is prevented by opioid receptor blockade

Journal of Clinical Endocrinology and Metabolism

Volumn 94, Issue 9, 2009, Pages 3372-3380

  Leu, James ^a   Cui, Min Hui ^a   Shamoon, Harry ^a   Gabriely, Ilan ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENALIN; BETA ENDORPHIN; C PEPTIDE; GLUCAGON; GLUCOSE; INSULIN; NALOXONE; NORADRENALIN; OPIATE RECEPTOR;

ADRENALIN BLOOD LEVEL; ADULT; ARTICLE; AUTONOMIC DYSFUNCTION; BODY MASS; CONTROLLED STUDY; CONVALESCENCE; DIABETES MELLITUS; FEMALE; GLUCAGON BLOOD LEVEL; GLUCONEOGENESIS; HUMAN; HUMAN EXPERIMENT; HYPOGLYCEMIA; INSULIN BLOOD LEVEL; MALE; NORADRENALIN BLOOD LEVEL; NORMAL HUMAN; PATHOGENESIS; PRIORITY JOURNAL;

EID: 69949109033     PISSN: 0021972X     EISSN: 0021972X     Source Type: Journal    
DOI: 10.1210/jc.2009-0882     Document Type: Article

References (36)

1. 1993 The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group. N Engl J Med 329:977-986
2. 1991 Epidemiology of severe hypoglycemia in the diabetes control and complications trial. The DCCT Research Group. Am J Med 90:450-459
3. Cryer PE 2002 The pathophysiology of hypoglycaemia in diabetes. Diabetes Nutr Metab 15:330-333; discussion 362
4. Cryer PE, Davis SN, Shamoon H 2003 Hypoglycemia in diabetes. Diabetes Care 26:1902-1912
5. Cryer PE 2001 Hypoglycemia-associated autonomic failure in diabetes. Am J Physiol Endocrinol Metab 281:E1115-E1121
6. Heller SR, Cryer PE 1991 Reduced neuroendocrine and symptomatic responses to subsequent hypoglycemia after 1 episode of hypoglycemia in nondiabetic humans. Diabetes 40:223-226
7. Davis SN, Tate D 2001 Effects of morning hypoglycemia on neuroendocrine and metabolic responses to subsequent afternoon hypoglycemia in normal man. J Clin Endocrinol Metab 86:2043-2050 (Pubitemid 32472917)
8. Davis MR, Mellman M, Shamoon H 1992 Further defects in counterregulatory responses induced by recurrent hypoglycemia in IDDM. Diabetes 41:1335-1340
9. Dagogo-Jack SE, Craft S, Cryer PE 1993 Hypoglycemia-associated autonomic failure in insulin-dependent diabetes mellitus. Recent antecedent hypoglycemia reduces autonomic responses to, symptoms of, and defense against subsequent hypoglycemia. J Clin Invest 91:819-828 (Pubitemid 23095255)
10. Levin BE, Dunn-Meynell AA, Routh VH 2002 CNS sensing and regulation of peripheral glucose levels. Int Rev Neurobiol 51:219-258
11. Nakao K, Nakai Y, Jingami H, Oki S, Fukata J, Imura H 1979 Substantial rise of plasma β-endorphin levels after insulin-induced hypoglycemia in human subjects. J Clin Endocrinol Metab 49:838-841 (Pubitemid 10171328)
12. Goldfarb AH, Jamurtas AZ 1997 β-Endorphin response to exercise. An update. Sports Medicine 24:8-16
13. Caprio S, Gerety G, Tamborlane WV, Jones T, Diamond M, Jacob R, Sherwin RS 1991 Opiate blockade enhances hypoglycemic counterregulation in normal and insulin-dependent diabetic subjects. Am J Physiol 260:E852-E858
14. Gabriely I, Shamoon H 2005 Fructose normalizes specific counterregulatory responses to hypoglycemia in patients with type 1 diabetes. Diabetes 54:609-616 (Pubitemid 40322061)
15. Gabriely I, Hawkins M, Vilcu C, Rossetti L, Shamoon H 2002 Fructose amplifies counterregulatory responses to hypoglycemia in humans. Diabetes 51:893-900 (Pubitemid 34438328)
16. Finegood DT, Bergman RN, Vranic M 1987 Estimation of endogenous glucose production during hyperinsulinemic-euglycemic glucose clamps. Comparison of unlabeled and labeled exogenous glucose infusates. Diabetes 36:914-924
17. Mellman MJ, Davis MR, Brisman M, Shamoon H 1994 Effect of antecedent hypoglycemia on cognitive function and on glycemic thresholds for counterregulatory hormone secretion in healthy humans. Diabetes Care 17:183-188 (Pubitemid 24065514)
18. Evans MI, Halter JB, Porte Jr D 1978 Comparison of double- and single-isotope enzymatic derivative methods for measuring catecholamines in human plasma. Clin Chem 24:567-570
19. Culebras JM, Moore FD 1977 Total body water and the exchangeable hydrogen. I. Theoretical calculation of nonaqueous exchangeable hydrogen in man. Am J Physiol 232:R54-R59
20. Landau BR, Wahren J, Chandramouli V, Schumann WC, Ekberg K, Kalhan SC 1995 Use of 2H2O for estimating rates of gluconeogenesis. Application to the fasted state. J Clin Invest 95:172-178
21. Dobbins RL, Malloy CR 2003 Measuring in-vivo metabolism using nuclear magnetic resonance. Curr Opin Clin Nutr Metab Care 6:501-509 (Pubitemid 40684570)
22. Steele R 1959 Influences of glucose loading and of injected insulin on hepatic glucose output. Ann NY Acad Sci 82:420-430
23. Cryer PE 2005 Mechanisms of hypoglycemia-associated autonomic failure and its component syndromes in diabetes. Diabetes 54:3592-3601
24. Davis SN, Shavers C, Mosqueda-Garcia R, Costa F 1997 Effects of differing antecedent hypoglycemia on subsequent counterregulation in normal humans. Diabetes 46:1328-1335 (Pubitemid 27315282)
25. Lecavalier L, Bolli G, Cryer P, Gerich J 1989 Contributions of gluconeogenesis and glycogenolysis during glucose counterregulation in normal humans. Am J Physiol 256:E844-E851
26. Kishore P, Gabriely I, Cui MH, Di Vito J, Gajavelli S, Hwang JH, Shamoon H 2006 Role of hepatic glycogen breakdown in defective counterregulation of hypoglycemia in intensively treated type 1 diabetes. Diabetes 55:659-666 (Pubitemid 43343221)
27. Somogyi AA, Barratt DT, Coller JK 2007 Pharmacogenetics of opioids. Clin Pharmacol Ther 81:429-444
28. Harbach H, Hell K, Gramsch C, Katz N, Hempelmann G, Teschemacher H 2000 β-Endorphin (1-31) in the plasma of male volunteers undergoing physical exercise. Psychoneuroendocrinology 25:551-562 (Pubitemid 30407308)
29. Shook JE, Kazmierski W, Wire WS, Lemcke PK, Hruby VJ, Burks TF 1988 Opioid receptor selectivity of beta-endorphin in vitro and in vivo: mu, delta and epsilon receptors. J Pharmacol Exp Ther 246:1018-1025 (Pubitemid 18232493)
30. Samardzić R, Jovanović-Mić ić D, Japindzić N, Beleslin DB 1990 β-Endorphin-induced behavioural effects: endorphin-catecholamines interactions. Acta Physiol Hung 75 Suppl:253-254
31. el-Tayeb KM, Brubaker PL, Lickley HL, Cook E, Vranic M 1986 Effect of opiate-receptor blockade on normoglycemic and hypoglycemic glucoregulation. Am J Physiol 250:E236-E242
32. Tendzegolskis Z, Viru A, Orlova E 1991 Exercise-induced changes of endorphin contents in hypothalamus, hypophysis, adrenals and blood plasma. Int J Sports Med 12:495-497
33. Radosevich PM, Lacy DB, Brown LL, Williams PE, Abumrad NN 1988 Effects of insulin-induced hypoglycemia on plasma and cerebrospinal fluid levels of ir-β-endorphins, ACTH, cortisol, norepinephrine, insulin and glucose in the conscious dog. Brain Res 458:325-338
34. Taborsky Jr GJ, Ahren B, Mundinger TO, Mei Q, Havel PJ 2002 Autonomic mechanism and defects in the glucagon response to insulin-induced hypoglycaemia. Diabetes Nutr Metab 15:318-322; discussion 322-323
35. Bolli GB 2003 Treatment and prevention of hypoglycemia and its unawareness in type 1 diabetes mellitus. Rev Endocr Metab Disord 4:335-341 (Pubitemid 37493649)
36. Fanelli CG, Epifano L, Rambotti AM, Pampanelli S, Di Vincenzo A, Modarelli F, Lepore M, Annibale B, Ciofetta M, Bottini P, Porcellati F, Scionti L, Santeusanio F, Brunetti P, Bolli GB 1993 Meticulous prevention of hypoglycemia normalizes the glycemic thresholds and magnitude of most of neuroendocrine responses to, symptoms of, and cognitive function during hypoglycemia in intensively treated patients with short-term IDDM. Diabetes 42:1683-1689 (Pubitemid 23318128)